| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.036 | 0.5 |